455 0

Full metadata record

DC FieldValueLanguage
dc.contributor.advisor이은규-
dc.contributor.author김원준-
dc.date.accessioned2018-04-18T06:06:42Z-
dc.date.available2018-04-18T06:06:42Z-
dc.date.issued2018-02-
dc.identifier.urihttps://repository.hanyang.ac.kr/handle/20.500.11754/68101-
dc.identifier.urihttp://hanyang.dcollection.net/common/orgView/200000432313en_US
dc.description.abstractAntibody drug conjugate (ADC) is one of the topics for the next generation oncology therapeutics because of its higher therapeutic index and potency. ADC consists of three basic components: antibody, linker, and cytotoxic drug. Many research has tried to optimize the combination of these components through conventional solution-phase conjugation, which requires purified antibody for conjugating and also multi-steps of buffer exchange and purification after conjugation. Solid-phase conjugation, in which antibody is first immobilized to solid matrix by affinity interaction, reduced by a reducing agent to expose the reactive thiol groups, and then a drug-linker complex is specifically conjugated to the immobilized antibody through thiol-maleimide reaction followed by ADC elution from the matrix. Solid-phase conjugation could be a viable alternative since it would circumvent several post-conjugation purification steps, and eventually achieve a higher conjugation yield. Also, the immobilization step in solid-phase conjugation process could achieve purification and conjugation step simultaneously; i.e., it could synthesize ADC directly from antibody secreting cell culture broth. In this study, we used Herceptin® (antibody), SMCC (linker), and doxorubicin (drug) for ADC synthesis. We performed the solid-phase conjugation of ADC from purified antibody solution (“neat solution”) and culture broth mimicking solution. The results are identical indicating that the solid-phase conjugation process is not significantly interfered by the culture broth ingredients. We also confirmed the reproducibility of solid-phase conjugation process, and characterized the synthesized ADC by RP-HPLC, size exclusion chromatography (SEC), MALDI-TOF/TOF mass spectrometer, surface plasmon resonance (SPR), and cellular cytotoxicity test. Protein A-based solid-phase conjugation process shows ca. 20% higher yield than the conventional solution-phase conjugation process, which suggests solid-phase conjugation process is a feasible and attractive process for ADC synthesis directly from cell culture broth.-
dc.publisher한양대학교-
dc.title고체상 접합기술을 이용한 항체-약물 복합체 (ADC)의 합성-
dc.title.alternativeApplication of solid-phase conjugation technology for synthesis of Antibody-Drug-Conjugate (ADC)-
dc.typeTheses-
dc.contributor.googleauthor김원준-
dc.contributor.alternativeauthorWONJUN KIM-
dc.sector.campusS-
dc.sector.daehak대학원-
dc.sector.department바이오나노학과-
dc.description.degreeMaster-
Appears in Collections:
GRADUATE SCHOOL[S](대학원) > BIONANOTECHNOLOGY(바이오나노학과) > Theses (Master)
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE